South Plainfield, NJ – December 21, 2015 – Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS).
“The genomic services business of Beckman Coulter is an ideal fit with GENEWIZ’s global strategy and expansion plans,” said Dr. Steve Sun, GENEWIZ Chairman and CEO. “Our two companies share a common mission and vision, to offer scientists around the world consistently-reliable genomics service solutions that will advance innovations and scientific discoveries.”
The synergies of this acquisition will support GENEWIZ’s global expansion strategy by leveraging GS’s 25+ years of genomics expertise and capabilities. GS’s comprehensive Sanger Sequencing, Next Generation Sequencing, Bioinformatics, and CLIA/Clinical services will complement GENEWIZ’s existing genomics services. With an international presence in the U.S. and a Pan-European presence centered in the UK, GS presents an immediate opportunity to strengthen GENEWIZ’s global access and value to customers through a stronger network of global labs and office locations in the U.S., UK, China, and Japan.
“GS’s proven leadership and experienced team of industry experts have built an efficient workflow that allows for the delivery of quality and timely results to its customers,” continued Dr. Sun. “The integration of these two businesses will allow for an increased level of service and value to customers worldwide. We look forward to working with the talented GS team to best serve our customers, and be an instrumental part of the future growth of GENEWIZ.”
GS and GENEWIZ will collaboratively align to ensure there is a seamless transition for both organizations and its customer base. The agreement has been approved by the boards of directors of both companies and closed effective immediately.
GENEWIZ is a leading genomics service company providing Sanger DNA sequencing, gene synthesis, next generation sequencing, molecular biology, bioinformatics, and GLP/CLIA regulatory services. The company leads the industry in outsourcing partnerships with pharmaceutical, clinical, biotechnology, academic, and government institutions. GENEWIZ is a global enterprise, headquartered in South Plainfield, NJ. Additional laboratory locations in the US include: Boston, Washington D.C. Metro, Research Triangle Park (North Carolina), San Diego, Los Angeles, San Francisco, and Seattle. GENEWIZ China is headquartered in Suzhou, China with an additional laboratory facility in Beijing. Other international locations include London and Tokyo.
About the genomic services business of Beckman Coulter
The genomic services business of Beckman Coulter, headquartered in Danvers, Massachusetts is a high quality provider of Next Generation and Sanger sequencing services with bioinformatics solutions serving healthcare businesses as well as academic and government institutions worldwide.